Log In
Print this Print this

custirsen sodium (OGX-011, TV-1011)

  Manage Alerts
Collapse Summary General Information
Company OncoGenex Pharmaceuticals Inc.
DescriptionSecond-generation antisense inhibitor of serum clusterin mRNA
Molecular Target Clusterin mRNA
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today